High-flow nasal oxygen for suspension laryngoscopy: a multicenter open-label study

J Int Med Res. 2022 Dec;50(12):3000605221140685. doi: 10.1177/03000605221140685.

Abstract

In this study, we aimed to assess the efficacy of high-flow nasal oxygen (HFNO) to maintain blood peripheral oxygen saturation (SpO2) in patients undergoing suspension laryngoscopy under general anesthesia. Adult patients were included in this bicenter study. After face-mask oxygenation, HFNO at a flow rate of 70 L min-1 and fraction of inspired oxygen 100% was initiated at loss of consciousness. At the end of HFNO, blood gas analysis was performed. Of the 29 included patients, five (17.2%; 95% confidence interval [CI]: 7.6-34.5) presented SpO2 <95% during the first 15 minutes of the procedure and eight patients (27.6%; 95% CI: 14.7-45.7) presented SpO2 <95% throughout the procedure. Six patients (20.7%; 95% CI: 9.8-38.4) required rescue jet ventilation. Median apnea time before SpO2 <95% was 13.5 (interquartile range [IQR]: 10-17.7) minutes. Arterial carbon dioxide tension at the end of the procedure or at the time of study discontinuation was 9.73 (IQR: 8.8-10.9) kPa and was higher than 8 kPa in 88.9% (95% CI: 71.9-96.1) of patients. HFNO was associated with a relatively high incidence of suboptimal oxygen saturation and hypercapnia during suspension laryngoscopy under general anesthesia and may not be considered the reference technique.

Keywords: General anesthesia; adult; airway management; apnea; larynx; surgery.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Anesthesia, General
  • Blood Gas Analysis
  • Humans
  • Laryngoscopy*
  • Nose
  • Oxygen Inhalation Therapy
  • Oxygen*

Substances

  • Oxygen